A longitudinal analysis of humoral, T cellular response and influencing factors in a cohort of healthcare workers: Implications for personalized SARS-CoV-2 …
E Sabetta, M Noviello, C Sciorati, M Viganò… - Frontiers in …, 2023 - frontiersin.org
Introduction SARS-CoV-2 mRNA vaccinations elicit both virus-specific humoral and T-cell
responses, but a complex interplay of different influencing factors, such as natural immunity …
responses, but a complex interplay of different influencing factors, such as natural immunity …
Measurement of IFN-γ and IL-2 for the assessment of the cellular immunity against SARS-CoV-2
G Safont, R Villar-Hernández, D Smalchuk… - Scientific Reports, 2024 - nature.com
The study of specific T-cell responses against SARS-CoV-2 is important for understanding
long-term immunity and infection management. The aim of this study was to assess the dual …
long-term immunity and infection management. The aim of this study was to assess the dual …
Evaluation of T cell responses with the QuantiFERON SARS-CoV-2 assay in individuals with 3 doses of BNT162b2 vaccine, SARS-CoV-2 infection, or hybrid immunity
MM Dourdouna, EB Tatsi, V Syriopoulou… - … and Infectious Disease, 2023 - Elsevier
Cellular immunity after SARS-CoV-2 infection or immunization may be important for long-
lasting protection against severe COVID-19 disease. We investigated cellular immune …
lasting protection against severe COVID-19 disease. We investigated cellular immune …
Dynamics of antibody and T cell immunity against SARS-CoV-2 variants of concern and the impact of booster vaccinations in previously infected and infection-naïve …
MR Faas, WA Mak, HY Markus, EM van der Zwan… - Vaccines, 2022 - mdpi.com
Despite previous coronavirus disease 2019 (COVID-19) vaccinations and severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, SARS-CoV-2 still causes a …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, SARS-CoV-2 still causes a …
Associations of HLA Polymorphisms with Anti-SARS-CoV-2 Spike and Neutralizing Antibody Titers in Japanese Rheumatoid Arthritis Patients Vaccinated with …
T Higuchi, S Oka, H Furukawa, S Tohma - Vaccines, 2023 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes Coronavirus
Disease 2019. Anti-SARS-CoV-2 spike (S) and neutralizing antibodies (Abs) are measured …
Disease 2019. Anti-SARS-CoV-2 spike (S) and neutralizing antibodies (Abs) are measured …
Interleukin‐2‐mediated CD4 T‐cell activation correlates highly with effective serological and T‐cell responses to SARS‐CoV‐2 vaccination in people living with HIV
A Gupta, E Righi, A Konnova… - Journal of Medical …, 2024 - Wiley Online Library
People living with HIV (PLWH) despite having an appreciable depletion of CD4+ T‐cells
show a good severe acute respiratory syndrome coronavirus 2 vaccination response. The …
show a good severe acute respiratory syndrome coronavirus 2 vaccination response. The …
[HTML][HTML] Susceptibility to reinfection with SARS-CoV-2 virus relative to existing antibody concentrations and T cell response
S Atef, F Al Hosani, L AbdelWareth, RH Al-Rifai… - International Journal of …, 2023 - Elsevier
Objectives We investigated the reinfection rate of vaccinated or convalescent immunized
SARS-CoV-2 in 952 expatriate workers with SARS-CoV-2 serological antibody (Ab) patterns …
SARS-CoV-2 in 952 expatriate workers with SARS-CoV-2 serological antibody (Ab) patterns …
An association study of HLA with the kinetics of SARS-CoV-2 spike specific IgG antibody responses to BNT162b2 mRNA vaccine
BNT162b2, an mRNA-based SARS-CoV-2 vaccine (Pfizer-BioNTech, New York, NY, USA),
is one of the most effective COVID-19 vaccines and has been approved by more than 130 …
is one of the most effective COVID-19 vaccines and has been approved by more than 130 …
Association of impaired fasting glucose and diabetes with SARS-CoV-2 spike antibody titers after the BNT162b2 vaccine among health care workers in a tertiary …
Background: Hyperglycemia can alter the activation of innate and acquired immunity, but
epidemiological evidence linking hyperglycemia to post-vaccination immunogenicity is …
epidemiological evidence linking hyperglycemia to post-vaccination immunogenicity is …
Cluster analysis identifies distinct patterns of T-cell and humoral immune responses evolution following a third dose of SARS-CoV-2 vaccine in people living with HIV
M El Moussaoui, S Desmecht, N Lambert, N Maes… - Viruses, 2023 - mdpi.com
(1) Background: Many vaccines require higher, additional doses or adjuvants to provide
adequate protection for people living with HIV (PLWH). Despite their potential risk of severe …
adequate protection for people living with HIV (PLWH). Despite their potential risk of severe …